Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 624

1.

Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.

Hui AB, Lo KW, Kwong J, Lam EC, Chan SY, Chow LS, Chan AS, Teo PM, Huang DP.

Mol Carcinog. 2003 Dec;38(4):170-8.

PMID:
14639656
3.

Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.

Tong JH, Ng DC, Chau SL, So KK, Leung PP, Lee TL, Lung RW, Chan MW, Chan AW, Lo KW, To KF.

BMC Cancer. 2010 Jun 3;10:253. doi: 10.1186/1471-2407-10-253.

4.

Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma.

Lung HL, Cheng Y, Kumaran MK, Liu ET, Murakami Y, Chan CY, Yau WL, Ko JM, Stanbridge EJ, Lung ML.

Int J Cancer. 2004 Nov 20;112(4):628-35.

5.

Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.

Liu XQ, Chen HK, Zhang XS, Pan ZG, Li A, Feng QS, Long QX, Wang XZ, Zeng YX.

Int J Cancer. 2003 Aug 10;106(1):60-5.

6.

Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.

Heller G, Fong KM, Girard L, Seidl S, End-Pfützenreuter A, Lang G, Gazdar AF, Minna JD, Zielinski CC, Zöchbauer-Müller S.

Oncogene. 2006 Feb 9;25(6):959-68.

PMID:
16205641
7.

Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma.

Yi HM, Li H, Peng D, Zhang HJ, Wang L, Zhao M, Yao KT, Ren CP.

Oncol Res. 2006;16(6):261-72.

PMID:
17476971
8.

Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.

Kwong J, Lo KW, Chow LS, Chan FL, To KF, Huang DP.

Int J Cancer. 2005 Jan 20;113(3):386-92.

9.

Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma.

Kwong J, Lo KW, Chow LS, To KF, Choy KW, Chan FL, Mok SC, Huang DP.

Neoplasia. 2005 Jan;7(1):67-74.

10.

TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.

Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T, Sekiya T, Reeves RH, Murakami Y.

Nat Genet. 2001 Apr;27(4):427-30.

PMID:
11279526
11.

Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.

Chow LS, Lo KW, Kwong J, Wong AY, Huang DP.

Oncol Rep. 2004 Oct;12(4):781-7.

PMID:
15375500
12.

Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.

Wang T, Liu H, Chen Y, Liu W, Yu J, Wu G.

J Exp Clin Cancer Res. 2009 Dec 30;28:160. doi: 10.1186/1756-9966-28-160.

13.

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.

Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ.

J Natl Cancer Inst. 2004 Feb 18;96(4):294-305.

PMID:
14970278
14.

NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.

Liu M, Peng Y, Wang X, Guo Q, Shen S, Li G.

BMC Cancer. 2010 Apr 27;10:160. doi: 10.1186/1471-2407-10-160.

15.

NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma.

Li W, Li X, Wang W, Li X, Tan Y, Yi M, Yang J, McCarthy JB, Xiong W, Wu M, Ma J, Su B, Zhang Z, Liao Q, Xiang B, Li G.

Carcinogenesis. 2011 Sep;32(9):1305-14. doi: 10.1093/carcin/bgr174. Epub 2011 Jul 28.

PMID:
21803736
16.

Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.

Lindsey JC, Lusher ME, Anderton JA, Bailey S, Gilbertson RJ, Pearson AD, Ellison DW, Clifford SC.

Carcinogenesis. 2004 May;25(5):661-8. Epub 2003 Dec 19.

PMID:
14688019
17.

TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.

Wang S, Xiao X, Zhou X, Huang T, Du C, Yu N, Mo Y, Lin L, Zhang J, Ma N, Murata M, Huang G, Zhang Z.

BMC Cancer. 2010 Nov 9;10:617. doi: 10.1186/1471-2407-10-617.

18.

Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.

Jansen M, Fukushima N, Rosty C, Walter K, Altink R, Heek TV, Hruban R, Offerhaus JG, Goggins M.

Cancer Biol Ther. 2002 May-Jun;1(3):293-6.

PMID:
12432281
19.

The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.

Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY, Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT, Tao Q.

Oncogene. 2007 Feb 8;26(6):934-44. Epub 2006 Jul 24.

PMID:
16862168
20.

Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.

Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S, Murakami Y.

Int J Cancer. 2003 Oct 20;107(1):53-9.

Supplemental Content

Support Center